Search Result "malignant behavior"
The Role of Vasodilator-stimulated Phosphoproteins in the Developmentof Malignant Tumors
Journal: Current Cancer Drug Targets
Volume: 24 Issue: 5 Year: 2024 Page: 477-489
Author(s):
Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Journal: Current Psychiatry Reviews
Volume: 9 Issue: 2 Year: 2013 Page: 111-119
Author(s): Stephan C. Mann, Stanley N. Caroff, Gabor S. Ungvari, E. Cabrina Campbell
Lactate in Solid Malignant Tumors: Potential Basis of a Metabolic Classification in Clinical Oncology
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2004 Page: 2195-2204
Author(s): S. Walenta, T. Schroeder, W. Mueller-Klieser
Malignant Hypercalcemia
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 3462-3467
Author(s): U. Basso, M. Maruzzo, A. Roma, V. Camozzi, G. Luisetto, F. Lumachi
The Possible Role of Infertility Drugs in Later Malignancy: A Review
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 9 Year: 2016 Page: 852-859
Author(s): Moshe Schaffer,Pamela Manuela Schaffer,Riad Kassem,Izhar Ben Shlomo
Genetics of Bladder Malignant Tumors in Childhood
Journal: Current Genomics
Volume: 17 Issue: 1 Year: 2016 Page: 14-32
Author(s): Andrea Zangari,Johan Zaini,Caterina Gulia
miR-488-3p Represses Malignant Behaviors and Facilitates Autophagy ofOsteosarcoma Cells by Targeting Neurensin-2
Journal: Current Pharmaceutical Biotechnology
Volume: 25 Issue: 10 Year: 2024 Page: 1264-1275
Author(s):
A Role of Immunotherapy in Metastatic Malignant Melanoma
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 182-188
Author(s): Timothy Allen,Lavanya Gundrajakuppam
Nucleic Acid-based Technologies in Therapy of Malignant Gliomas
Journal: Current Pharmaceutical Biotechnology
Volume: 12 Issue: 1 Year: 2011 Page: 1805-1822
Author(s): Monika Piwecka, Katarzyna Rolle, Eliza Wyszko, Ryszard Zukiel, Stanislaw Nowak, Miroslawa Z. Barciszewska, Jan. Barciszewski
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and CisplatinResistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-cateninPathway and PI3K/AKT Pathway
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 11 Year: 2022 Page: 2098-2108
Author(s): Yuhang Quan,Shanshan Li,Yahong Wang,Guangshun Liu,Zhiyong Lv,Zhonghui Wang